Key Statistics
Market Cap$939.47M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.24
52W High$18.69
52W Low$6.92
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees260
Price Performance
1 Week+12.86%
3 Month-10.23%
1 Year+47.41%
FinancialsAnnual · QuiverQuant
Revenue$168.34M
Assets$952.69M
Liabilities$283.56M
Net Income$126.25M loss
About
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed to treat cancer patients and autoimmune diseases in the United States and internationally. The company is headquartered in Monrovia, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze XNCR with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.